• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对引入 COVID-19 疾病疫苗的统计力学研究。

Statistical mechanics study of the introduction of a vaccine against COVID-19 disease.

机构信息

INFN-TIFPA Trento Institute of Fundamental Physics and Applications, Via Sommarive, 14, 38123 Povo, Trento, Italy.

European Centre for Theoretical Studies in Nuclear Physics and Related Areas (ECT*), Strada delle Tabarelle 286, I-38123 Villazzano, Trento, Italy.

出版信息

Phys Rev E. 2021 Jul;104(1-1):014132. doi: 10.1103/PhysRevE.104.014132.

DOI:10.1103/PhysRevE.104.014132
PMID:34412259
Abstract

By the end of 2020, a year since the first cases of infection by the Covid-19 virus have been reported; several pharmaceutical companies made significant progress in developing effective vaccines against the Covid-19 virus that has claimed the lives of more than 10^{6} people over the world. On the other hand, there is growing evidence of re-infection by the virus, which can cause further outbreaks. In this paper, we apply statistical physics tools to examine theoretically the vaccination rate required to control the pandemic for three different vaccine efficiency scenarios and five different vaccination rates. Also, we study the effect of temporal restrictions or reliefs on the pandemic's outbreak, assuming that re-infection is possible. When examining the efficiency of the vaccination rate of the general population in preventing an additional outbreak of the disease, we find that a high vaccination rate (where 0.3% of the population is vaccinated daily, which is equivalent to ≈10^{6} vaccine doses in the United States daily) is required to gain control over the spread of the virus without further restrictions.

摘要

截至 2020 年底,自首次报告感染新冠病毒病例以来已经过去了一年;几家制药公司在开发针对已导致全球超过 100 万人死亡的新冠病毒的有效疫苗方面取得了重大进展。另一方面,越来越多的证据表明病毒会再次感染,这可能导致进一步的爆发。在本文中,我们应用统计物理工具理论上研究了在三种不同的疫苗效率情况下和五种不同的接种率下控制大流行所需的接种率。此外,我们还研究了在假设再次感染是可能的情况下,对大流行爆发的时间限制或缓解的影响。当研究普通人群的疫苗接种率在防止疾病再次爆发方面的效率时,我们发现需要高接种率(每天有 0.3%的人口接种疫苗,这相当于美国每天接种 ≈10^6 剂疫苗)才能在没有进一步限制的情况下控制病毒的传播。

相似文献

1
Statistical mechanics study of the introduction of a vaccine against COVID-19 disease.对引入 COVID-19 疾病疫苗的统计力学研究。
Phys Rev E. 2021 Jul;104(1-1):014132. doi: 10.1103/PhysRevE.104.014132.
2
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.mRNA 疫苗诱导的 T 细胞对 SARS-CoV-2 关切变异株的反应完全相同,但根据先前的感染状态,其持久性和归巢特性存在差异。
Elife. 2021 Oct 12;10:e72619. doi: 10.7554/eLife.72619.
3
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
4
Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects.基于模型的奥地利 SARS-CoV-2 免疫水平估计及其对群体免疫效果的影响。
Sci Rep. 2022 Feb 21;12(1):2872. doi: 10.1038/s41598-022-06771-x.
5
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.智利科兴和国药疫苗接种后动态 IgG 血清阳性率:哨点监测研究。
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
6
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
7
An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.一种基于鼻腔内的 OMV 疫苗可诱导针对 SARS-CoV-2 感染的高黏膜和全身保护免疫。
Front Immunol. 2021 Dec 17;12:781280. doi: 10.3389/fimmu.2021.781280. eCollection 2021.
8
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2(Delta)变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络,2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
9
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
10
COVID-19 Immunity in the Cohort of IRCCS San Raffaele Hospital Employees after BNT162b2 Vaccination: A Retrospective Observational Study.辉瑞-BioNTech 疫苗接种后意大利圣拉斐尔医院员工队列的 COVID-19 免疫:一项回顾性观察研究。
Ann Ig. 2024 Jul-Aug;36(4):432-445. doi: 10.7416/ai.2024.2615. Epub 2024 Feb 22.

引用本文的文献

1
Over- and under-estimation of vaccine effectiveness.疫苗效力的高估与低估。
BMC Med Res Methodol. 2025 Jul 1;25(1):163. doi: 10.1186/s12874-025-02611-4.
2
MAM: Flexible Monte-Carlo Agent based model for modelling COVID-19 spread.MAM:用于模拟 COVID-19 传播的灵活的基于蒙特卡罗代理的模型。
J Biomed Inform. 2023 May;141:104364. doi: 10.1016/j.jbi.2023.104364. Epub 2023 Apr 13.
3
The role of models in the covid-19 pandemic.模型在新冠疫情大流行中的作用。
Isr J Health Policy Res. 2022 Oct 20;11(1):36. doi: 10.1186/s13584-022-00546-5.
4
Multi-population analysis of the Cuban SARS-CoV-2 epidemic transmission before and during the vaccination process.古巴在疫苗接种过程之前和期间SARS-CoV-2疫情传播的多群体分析。
Phys Fluids (1994). 2021 Oct;33(10):107107. doi: 10.1063/5.0066912. Epub 2021 Oct 8.